Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-15

Clinical Trial Update: Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial of netarsudil ophthalmic solution in Japanese and Japanese-American subjects with open-angle glaucoma or ocular hypertension completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • netarsudil ophthalmic solution (netarsudil)

Snippet

Sponsor: Aerie Pharmaceuticals | Conditions: Primary Open Angle Glaucoma or Ocular Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2019-11-15